Avadel Pharmaceuticals plc (AVDL) financial statements (2020 and earlier)

Company profile

Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
DUBLIN, 15
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6472798013125147
Cash and cash equivalents1013171091812
Short-term investments546062703107135
Receivables10101214141117
Inventory, net of allowances, customer advances and progress billings4234566
Inventory4234566
Prepaid expense2333245
Other current assets00010  
Other undisclosed current assets31119111
Total current assets:828997102125148175
Noncurrent Assets
Property, plant and equipment1112222
Intangible assets, net (including goodwill)19202020208889
Goodwill18181818181818
Intangible assets, net (excluding goodwill)111126971
Other noncurrent assets39353536362522
Other undisclosed noncurrent assets10121313766
Total noncurrent assets:6967697165121120
TOTAL ASSETS:151156166174190269295
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26212119253233
Accounts payable645441111
Accrued liabilities20171615222121
Taxes payable    0  
Debt 000000
Due to related parties688991114
Contract with customer, liability0  
Other liabilities4242323
Other undisclosed current liabilities1211 22
Total current liabilities:36323431384752
Noncurrent Liabilities
Long-term debt and lease obligation122120119117116114113
Long-term debt, excluding current maturities122120119117116114113
Liabilities, other than long-term debt21282831334252
Due to related parties12141618192838
Other liabilities9141213141414
Other undisclosed noncurrent liabilities2344   
Total noncurrent liabilities:145151150152149156165
Total liabilities:181183183183188203217
Stockholders' equity
Stockholders' equity attributable to parent(29)(27)(18)(10)36679
Common stock0000000
Treasury stock, value(50)(50)(50)(50)(50)(50)(50)
Additional paid in capital434434434434434433430
Accumulated other comprehensive loss(23)(23)(23)(23)(23)(24)(24)
Accumulated deficit(391)(388)(380)(371)(358)(294)(278)
Total stockholders' equity:(29)(27)(18)(10)36679
TOTAL LIABILITIES AND EQUITY:151156166174190269295

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues11141816212029
Cost of revenue(7)(3)(4)(3)(7)(3)(4)
Cost of goods and services sold(2)(3)(4)(3)(4)(3)(4)
Gross profit:4111413141726
Operating expenses(12)(16)(18)(21)(89)(31)(29)
Operating loss:(7)(4)(4)(8)(75)(14)(3)
Nonoperating income (expense)(1)11(2)012
Investment income, nonoperating(1)11(2)(0)01
Other nonoperating income (expense)0(0)(0)(0)001
Interest and debt expense(3)(3)(3)(3)(3)(3)(3)
Loss from continuing operations before income taxes:(12)(7)(7)(13)(78)(16)(4)
Income tax expense (benefit)9(2)(2)01510
Net loss available to common stockholders, diluted:(3)(9)(9)(13)(64)(16)(3)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(3)(9)(9)(13)(64)(16)(3)
Other comprehensive income (loss) (0)0  (0)(0)
Other undisclosed comprehensive income    0  
Comprehensive loss:(3)(9)(8)(13)(64)(16)(3)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0  000(0)
Comprehensive loss, net of tax, attributable to parent:(3)(9)(8)(13)(64)(16)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: